In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's disease

Dirk A. Ridder, Markus Schwaninger*

*Korrespondierende/r Autor/-in für diese Arbeit
10 Zitate (Scopus)

Abstract

The oral antidiabetic thiazolidinediones exert protective effects in models of Parkinson's disease and other neurological diseases. While the antidiabetic effect is due to activation of PPAR?, the mechanisms underlying the neuroprotection are more controversial. It may involve activation of PPAR? blocking inflammation and apoptosis. However, new evidence suggests an antioxidative PPAR?-independent action. Here we discuss recent data on the mode of action of TZDs in models of PD and their implication for the translation into the clinic.

OriginalspracheEnglisch
ZeitschriftExperimental Neurology
Jahrgang238
Ausgabenummer2
Seiten (von - bis)133-137
Seitenumfang5
ISSN0014-4886
DOIs
PublikationsstatusVeröffentlicht - 01.12.2012

Fingerprint

Untersuchen Sie die Forschungsthemen von „In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's disease“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren